Eli Lilly announces progress on new headache medications [MarketWatch]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: MarketWatch
Eli Lilly announces progress on new headache medications Eli Lilly & Co. LLY, -0.26% announced early Wednesday that it has made progress on two migraine therapies, including submitting an application for one medication -- intended for in-the-moment pain relief for migraines -- to the U.S. Food and Drug Administration. If that drug, lasmiditan, is approved, "it could represent the first significant innovation for the acute treatment of migraine in more than two decades," Eli Lilly said. The drugmaker also said that the FDA had granted a "breakthrough therapy" designation to the company's therapy Emgality to prevent episodic cluster headaches; the designation is geared at speeding the development and review of innovative drugs. Emgality was approved in late September to prevent migraines, one of a number of new preventive migraine treatments ; cluster headache is another, rare type of headache disorder. There are currently no approved preventive therapies for the condition in the U.S
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings? [Yahoo! Finance]Yahoo! Finance
- 4 Large Drug Stocks to Hold on to Amid Industry Challenges [Yahoo! Finance]Yahoo! Finance
- Wegovy Access Expands to Millions in US on Medicare, Study Finds [BNN Bloomberg (Canada)]BNN Bloomberg
- Biogen Profit Beats Street Estimates as Cost-Cutting Takes Hold [BNN Bloomberg (Canada)]BNN Bloomberg
- Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/6/24 - Miss
LLY
Sec Filings
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- LLY's page on the SEC website